Cargando…

GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trial

BACKGROUND: GLPG1205 is a selective functional antagonist of G-protein-coupled receptor 84, which plays an important role in fibrotic processes. This study assessed the efficacy, safety and tolerability of GLPG1205 for treatment of idiopathic pulmonary fibrosis (IPF). METHODS: PINTA (ClinicalTrials....

Descripción completa

Detalles Bibliográficos
Autores principales:	Strambu, Irina R., Seemayer, Christian A., Fagard, Liesbeth M-C.A., Ford, Paul A., Van der Aa, Tom A.K., de Haas-Amatsaleh, Angela A., Modgill, Vikas, Santermans, Eva, Sondag, Eric N., Helmer, Eric G., Maher, Toby M., Costabel, Ulrich, Cottin, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978158/ https://www.ncbi.nlm.nih.gov/pubmed/36328358 http://dx.doi.org/10.1183/13993003.01794-2022

Ejemplares similares

GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects
por: Timmis, Helen, et al.
Publicado: (2021)

Safety, Pharmacokinetics, and Pharmacodynamics of the Autotaxin Inhibitor GLPG1690 in Healthy Subjects: Phase 1 Randomized Trials
por: van der Aar, Ellen, et al.
Publicado: (2019)

Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies
por: Desrivot, Julie, et al.
Publicado: (2021)

CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy
por: de Poel, Eyleen, et al.
Publicado: (2021)

Population Pharmacokinetic and Pharmacodynamic Analysis of GLPG1690, an Autotaxin Inhibitor, in Healthy Volunteers and Patients with Idiopathic Pulmonary Fibrosis
por: Taneja, Amit, et al.
Publicado: (2019)

Pharmacokinetics and Metabolism of Ziritaxestat (GLPG1690) in Healthy Male Volunteers Following Intravenous and Oral Administration
por: Helmer, Eric, et al.
Publicado: (2021)

Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)
por: Maher, Toby M, et al.
Publicado: (2019)

MicroRNA-1205 Regulation of FRYL in Prostate Cancer
por: Naidoo, Michelle, et al.
Publicado: (2021)

Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects
por: Namour, Florence, et al.
Publicado: (2016)

The Rhomboid Protease GlpG Promotes the Persistence of Extraintestinal Pathogenic Escherichia coli within the Gut
por: Russell, Colin W., et al.
Publicado: (2017)

Steric trapping reveals a cooperativity network in the intramembrane protease GlpG
por: Guo, Ruiqiong, et al.
Publicado: (2016)

Identifying the molecular target sites for CFTR potentiators GLPG1837 and VX-770
por: Yeh, Han-I, et al.
Publicado: (2019)

The rhomboid protease GlpG has weak interaction energies in its active site hydrogen bond network
por: Gaffney, Kristen A., et al.
Publicado: (2019)

Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women
por: Elhassan, Yasir S, et al.
Publicado: (2018)

1205. Emergence of Carbapenemase Producing Enterobacteriaceae in South Central Ontario, Canada
por: Zhong, Zoe, et al.
Publicado: (2018)

Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Modeling of Filgotinib (GLPG0634), a Selective JAK1 Inhibitor, in Support of Phase IIB Dose Selection
por: Namour, Florence, et al.
Publicado: (2015)

How to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an Example
por: Meyer, Claudia, et al.
Publicado: (2022)

MA12.05 The Impact of the COVID-19 Pandemic on Post-Operative Outcomes of Thoracic Cancer Surgery in Canada
por: Huynh, C., et al.
Publicado: (2021)

1205. Vaccine Hesitancy in Paediatric Practice and Predictors of Physician-Reported Vaccine Compliance
por: Allan, Kate E
Publicado: (2021)

Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization
por: Blanqué, Roland, et al.
Publicado: (2014)

C-reactive protein gene rs1205 polymorphism is not associated with the risk of colorectal cancer
por: Fang, Dilong, et al.
Publicado: (2017)

Unactivated leukocyte expression of C-reactive protein is minimal and not dependent on rs1205 genotype
por: Best, L. G., et al.
Publicado: (2021)

P1205: A LIVING PATIENT-DERIVED BIOREPOSITORY FOSTERING MICROENVIRONMENT DISSECTION IN T-CELL LYMPHOMA
por: Fiore, Danilo, et al.
Publicado: (2023)

Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators
por: de Wilde, Gert, et al.
Publicado: (2019)

Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS‐5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip
por: van der Aar, Ellen, et al.
Publicado: (2021)

1205. Healthcare Personnel Knowledge, Attitudes, and Beliefs Towards Infection Prevention and Control Measures for Protection from Respiratory Infections
por: Bessesen, Mary T, et al.
Publicado: (2019)

C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205
por: Enocsson, Helena, et al.
Publicado: (2021)

Complete Genome Sequence of a γ-Hexachlorocyclohexane-Degrading Bacterium, Sphingobium sp. Strain MI1205
por: Tabata, Michiro, et al.
Publicado: (2016)

CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1
por: Zhang, Ruirui, et al.
Publicado: (2021)

miR-1205/DNAJB1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53/TAp63 signaling: miR-1205/DNAJB1 reverses docetaxel chemoresistance in TNBC
por: Yin, Yongxiang, et al.
Publicado: (2021)

Antitumorigenic Effects of Inhibiting Ephrin Receptor Kinase Signaling by GLPG1790 against Colorectal Cancer Cell Lines In Vitro and In Vivo
por: Colapietro, Alessandro, et al.
Publicado: (2020)

A dose escalating phase I study of GLPG0187, a broad spectrum integrin receptor antagonist, in adult patients with progressive high-grade glioma and other advanced solid malignancies
por: Cirkel, Geert A., et al.
Publicado: (2016)

Reporting rates of adverse reactions to specialty care medicines exhibit a direct positive correlation with patient exposure: A lack of evidence for the Weber effect
por: Modgill, Vikas, et al.
Publicado: (2020)

CRP-level-associated polymorphism rs1205 within the CRP gene is associated with 2-hour glucose level: The SAPPHIRe study
por: Sheu, Wayne Huey-Herng, et al.
Publicado: (2017)

TREATMENT OF THIRD DEGREE INTERNAL HEMORRHOIDS WITH XIAO ZHI LING INJECTION: (A CLINICAL INVESTIGATION OF 1205 CASES)
por: Xiu-Zhang, Shi
Publicado: (1983)

Alport Syndrome: De Novo Mutation in the COL4A5 Gene Converting Glycine 1205 to Valine
por: Antón-Martín, Pilar, et al.
Publicado: (2012)

C-reactive protein gene rs1205 polymorphism is associated with low-grade chronic inflammation in postmenopausal women
por: de Santis, Iriane Prado, et al.
Publicado: (2020)

Long-term clinical and real-world experience with pirfenidone in the treatment of idiopathic pulmonary fibrosis
por: Cottin, Vincent, et al.
Publicado: (2015)

Influence of age and renal impairment on the steady state pharmacokinetics of filgotinib, a selective JAK1 inhibitor
por: Namour, Florence, et al.
Publicado: (2018)

Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma
por: Li, Pei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_77lpetsn83vuv9l68479f60o37